Leishmaniasis is an infectious disease that is endemic in tropical areas and in the Mediterranean. This condition spreads to 98 countries in four continents, surpassing 12 million infected individuals, with 350 million people at risk of infection. This disease is characterized by a wide spectrum of clinical syndromes, caused by protozoa of the genus Leishmania, with various animal reservoirs, s...

Objective: Leishmaniasis is endemic in 88 countries with incidence rate of 1.5-2 million; the most common form of leishmaniasis is cutaneous leishmaniasis (CL) with 1.5 million new cases per year. Correct diagnosis and characterization of the particular parasite is important for evaluating prognosis and prescribing appropriate treatment. The current management of leishmaniasis is drug treatment...

Leishmaniasis is a well-documented disease of humans and animals worldwide. In humans, leishmaniasis is generally zoonotic with a number of different clinical manifestations ranging from single or multiple skin lesions (cutaneous leishmaniasis) to destruction of the mucosae, including the soft cartilage of the nasal septum (mucocutaneous leishmaniasis) or systemic infections of the liver and sp...

Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where in the world HIV/VL coinfection has become endemic. The case here suffers from both AIDS and visceral-cutaneous leishmaniasis. We report an Ira...

Identification of Cutaneous Leishmaniasis-causing Species Using Semi-Nested PCR in Kohgiluyeh and Boyer-Ahmad Province During 2013-2019

Leishmaniasis is a parasitic disease that is transmitted through a bite of some species of sandflies. It is caused by obliged intra-cellular protozoa of the genus Leishmania and is responsible for a broad spectrum of clinical syndromes: cutaneous leishmaniasis (CL), visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (ML). The visceral disease (classically known as "kala azar") is the m...

Leishmaniasis has been classified primarily as a vector-borne disease that poses a major problem to public health. The Biskra region, which has long been known as a focal point for cutaneous leishmaniasis, has a low extent of visceral leishmaniasis. The aim of the study is to highlight the spatial and temporal evolution of cutaneous and visceral leishmaniasis in Biskra over the last decade, tak...

Cutaneous leishmaniasis is caused by different species of the Leishmania genus. Leishmania(Leishmania) infantum, causing cutaneous leishmaniasis, has been described in patients living in areas where visceral leishmaniasis is endemic. In this study, it was possible to characterize this species in seven slides from cutaneous tissue imprints from patients with cutaneous leishmaniasis in the State ...

Cutaneous leishmaniasis is rare in Nepal although visceral leishmaniasis (kala azar) is common in the Terai region. In country like ours where tuberculosis is more prevalent cutaneous leishmaniasis is very likely to be mistreated as cutaneous tuberculosis, especially lupus vulgaris. Here we report a series of four cases of cutaneous leishmaniasis who presented in the out patient department at T...